The size of the General Surgical Devices Market in the Middle-East and Africa was worth USD 1.80 billion in 2022 and estimated to reach USD 3.12 billion by the end of 2027, growing at a CAGR of 11.656% between 2022 to 2027.
Increased prevalence of gynecological and neurological disorders, demand for minimally invasive devices, injuries and accidents causing more outpatient surgeries, increased focus on medical device R&D skills and adoption of advanced health technologies, awareness and demand for cosmetic dentistry and cosmetology, and increased spending for health infrastructure development, in particular especially in the developing economies are the significant factors attributable to the growth of the MEA general surgical devices market. In sub-Saharan Africa, by 2030, heart disease and kidney failure will become the leading causes of death, and chronic disease will account for 42% of all deaths in the region, up from 28% in 2015, according to WHO. According to the Heart and Stroke Foundation South Africa, five people have heart attacks every hour in South Africa, ten people have strokes, and ten people will die from these events. These numbers will drive the market in the near future. The rise of chronic diseases eventually increases the surgeries, estimated to drive the general surgical devices market in MEA.
Many innovations have been made due to the need for high reliability, precision, and minimal invasive. Other vital factors expected to drive the market growth include increased investment in the healthcare sector and increasing adoption of 3D printing technology in surgical procedures. In addition, a high senior population, good medical tourism, and international companies in the region, especially in the United Arab Emirates and Saudi Arabia, will be the driving force of the market in the years to come. According to the WHO, the world population aged 60 and over is expected to reach 2.5 billion in 2050 compared to 966 million in 2016. Medical robotics and computer-assisted surgery devices are expected to experience the maximum CAGR due to preference for minimally invasive surgeries, increased investment in R&D, and availability of technologically advanced products.
The high investment costs required for the production of surgical equipment, lack of skilled labor, and strict regulatory authorities leading to delayed approvals may restraint the MEA general surgical devices market.
This research report on the MEA general surgical devices market has been segmented & sub-segmented into the following categories:
By End User:
Geographically, the African market is expected to grow at the highest CAGR during the forecast period in the MEA region owing to technological advancements. Increased investment by international key players is expected to fuel the market’s growth rate. At the same time, limited healthcare facilities will restrain the market's growth in the African region, especially in the sub-Saharan countries. The high number of aging populations and traffic accident cases in the region coupled with government reimbursement policies in emerging economies is expected to drive this regional market over the forecast period. In addition, the senior population is more susceptible to several diseases, which is likely to increase the need for treatments in South Africa.
The United Arab Emirates had the second-largest share in MEA general surgical devices market in 2020. The availability of various surgical products, the vast patient population, and more medical ailments drive the overall MEA market. In 2015, approximately a million people in the region were diagnosed with chronic diseases. In addition, by 2027, it is estimated that nearly one in two people (47%) will contract some chronic illness at some point in their life. Additionally, the exemplary medical tourism sector will increase the available surgical devices in the region.
On the other hand, Iraq is estimated to account for the lowest share of the MEA general surgical devices market during the forecast period due to a poor economy with low per capita income. In addition, most of the market in this region is overburdened by social stigma related to surgeries and a flawed healthcare system.
KEY MARKET PLAYERS:
A few of the noteworthy companies operating in the MEA general surgical devices market profiled in this report are Medtronic Plc., Stryker Corporation, Johnsons And Johnsons, Conmed Corporation, Alcon Laboratories Inc., Smith & Nephew PLC, Zimmer Holdings Inc., Boston Scientific Corporation, B. Braun Melsungen AG, KLS Martin Group, Olympus Corporation, Applied Medical Resources Corporation, Microline Surgicals, Inc., Karl Storz GmbH & Co. Kg, Cook Medical Incorporated, and Teleflex Incorporated.
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: firstname.lastname@example.org